Feeding Frenzy Over Science Fraud

Congress is in a tizzy; science leaders are worried legislation could do harm to the innocent WASHINGTON--Fraud in science has become a cause célébre among Washington politicians. For a two-week period this spring, it seemed that everywhere one looked there were concerned and aggrieved congressmen. And as the politicians aired the dirty linen of science in public and fulminated over measures they claimed needed to be taken to assure the public that science would be pursued in a spot

Written byAj Hostetler
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

WASHINGTON--Fraud in science has become a cause célébre among Washington politicians. For a two-week period this spring, it seemed that everywhere one looked there were concerned and aggrieved congressmen. And as the politicians aired the dirty linen of science in public and fulminated over measures they claimed needed to be taken to assure the public that science would be pursued in a spotless fashion, scientists voiced fears that congressional meddling would make their lives more worse, cripple the scientific enterprise.

Over in the House, Rep. John Dingell was fuming about NIH’s response to allegations from Margot O'Toole, a former MIT postdoc, about the conduct of Nobel laureate David Baltimore and one of his associates who authored a now-controversial 1986 paper on gene expression. "You never talked to Dr. O’Toole?" Dingeil asked Mary Miers, NIH’s misconduct officer. "How do you conduct an investigation without talking to the person who has the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies